Stockreport

Elevation Oncology reports data from Phase I trial of EO-3021 for solid tumours [Yahoo! Finance]

Elevation Oncology, Inc. - Common stock  (ELEV) 
PDF The trial focuses on assessing EO-3021 in treating various cancers, including gastric, gastroesophageal junction (GEJ), pancreatic, and oesophageal cancers. As of 10 [Read more]